Latest news with #CannabixTechnologies
Yahoo
3 days ago
- Business
- Yahoo
Omega Laboratories Delivers Marijuana Breath Test Validation Packet to Cannabix Technologies Inc. - Completing Major Milestone under Strategic Partnership
VANCOUVER, British Columbia, June 05, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the 'Company or Cannabix') reports that Omega Laboratories Inc. of Ohio, USA ('Omega Laboratories' or 'Omega') a leading drug testing laboratory renowned for its comprehensive services has delivered a Validation Packet for Omega's Laboratory Developed Test Method to test delta9 THC analytes in relation to the Cannabix Marijuana Breath Test ('MBT') technology (Figure 1). The Validation Packet was performed in Omega's ISO/IEC 17025 accredited laboratory environment following their Quality Management System. This validation included a test method for the simultaneous quantification of Δ-9-tetrahydrocannabinol (THC), Δ-8-THC, cannabidiol (CBD), and cannabinol (CBN) in breath aerosols collected using Cannabix Technologies' Breath Collection Unit (BCU) and Breath Cartridges (BC). The delivery of the Validation Packet completes a major milestone under the strategic partnership and development agreement ('SPDA') between Cannabix and Omega. This establishes Omega and Cannabix as the premier technology for collecting and testing breath for recent marijuana usage. Cannabix's MBT is a lab-based, collect and send solution, focused on 'recent use' detection of delta-9 THC as opposed to urine, blood and saliva methods (that can detect delta-9 THC many hours, days, or even weeks after consumption). (1) Omega Laboratories is an international industry leader in forensic drugs of abuse testing for over twenty years. Omega has multiple federal as well as international certifications and accreditations for its world class facility and has extensive experience in novel technology for detection of drugs of abuse. Cannabix and Omega are moving quickly to launch with select key clients and ramping up commercialization efforts for the Marijuana Breath Test. Omega Laboratories is currently integrating breath testing using Cannabix Breath Cartridges into its suite of services and testing protocols. Among various initiatives underway the Company and Omega are working together on marketing, distribution, support, manufacturing and logistics for the 1. Cannabix Marijuana Breath Test (BCU and Breath Cartridge) Under the SPDA, in consideration for the completion and delivery of the Validation Packet by Omega, the Company will convert 3 million Special Warrants into Special Warrant Shares to Omega. Furthermore, Omega will have the right to appoint one person to the board of directors of the Company in due course. (1) Olla P, Ishraque MT, Bartol S. 2020. Evaluation of Breath and Plasma Tetrahydrocannabinol Concentration Trends Postcannabis Exposure in Medical Cannabis Patients. Cannabis and Cannabinoid Res.; 99-104. About Omega Laboratories, Inc. Omega Laboratories, headquartered in Mogadore, Ohio with an additional state-of-the-art facility in Ontario, Canada provides laboratory-based advanced testing solutions to over 6,000 clients worldwide. Omega Laboratories has over 24 years of experience in pioneering innovative drug testing methodologies, specializing in the detection of drugs of abuse utilizing Hair, Oral Fluid, Urine and Breath specimens. Omega continues to innovate with the launch of their Technical Solutions portfolio that incorporates a paperless Custody & Control Form system (oCCF) in fourteen languages, licensure of a Laboratory Information Management System (LIMS) designed specifically for Toxicology and powers new laboratories in countries that have demand for local service providers. About Cannabix Technologies Inc. Cannabix Technologies Inc. is a developer of marijuana and alcohol breath technologies for workplaces, law enforcement and other settings. Breath testing for delta-9 THC (the primary psychoactive ingredient in cannabis) focuses on recent marijuana use. Cannabix is the developer of the BreathLogix autonomous alcohol screening device for organizations who strive to improve alcohol safety and monitoring We seek Safe Harbor. On behalf of the Board of Directors 'Rav Mlait' CEOCannabix Technologies Inc. For further information, contact the Company at The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release. Cautionary Statement Regarding Forward-Looking StatementsThis news release contains certain "forward-looking statements" within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as "anticipates," "plan," "continue," "expect," "project," "intend," "believe," "anticipate," "estimate," "may," "will," "potential," "proposed," "positioned" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements in this news release include, but are not limited to, statements relating to: certification of devices, acceptance of devices by international regulators, the achievement of any or all of the goals and aims of the strategic partnership and development agreement with Omega Laboratories; the completion of pre-validation or validation testing described in this news release; final development of a commercial or prototype product(s); the successful trial or pilot of company technologies; the commercialization of the Company's products; the negotiation and potential entry into additional agreements with distributors; and the completion of future financings. There are numerous risks and uncertainties that could cause actual results and the Company's plans and objectives to differ materially from those expressed in the forward-looking information. Important factors that could cause actual results to differ materially from those expressed in the forward-looking information include (but are note limited to): adverse market conditions; risks regarding protection of proprietary technology; the ability of the Company to complete future financings; the ability of the Company to develop and market its future product; risks regarding government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition; that Omega may not complete all or any of the milestones as contemplated strategic partnership and development agreement with Omega Laboratories; that the CSE may not approve the issuance of the securities; that the Company's development of breathalyzer technology will provide any benefit to the Company; there is no assurance that any proposed new products will be built, will be successful in beta testing or clinical trials; there is no assurance that the Company will enter into any partnerships to advance any of its corporate initiatives or technologies; there is no assurance that any 'patent pending' or 'provisional patents' technologies licensed by the Company or owned by the Company will receive patent status by regulatory authorities; the Company is not currently selling breathalyzers and there is no assurance that the Company ever will; and other factors beyond the control of the Company. Actual results and future events could differ materially from those anticipated in such information. These and all subsequent written and oral forward-looking information are based on estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. Except as required by law, the Company does not intend to update these forward-looking statements. A photo accompanying this announcement is available at in to access your portfolio
The Market Online
02-05-2025
- Business
- The Market Online
Cannabis Report: Breathalyzers, record cash flow, & the funk
An innovator in cannabis and alcohol breathalyzers, signed a non-exclusive North American distribution agreement with Alco Prevention Canada. The agreement covers an autonomous alcohol breathalyzer devices, whose patent pending pre-calibrated cartridge system promises to save time and money associated with calibration equipment and site visits from technicians. (Source: Cannabix Technologies) Click here for the full story. 1 | Aurora Cannabis completes multimillion dollar investment and renaming of B.C. manufacturing facility 2 | SNDL reports record gross margin and positive cash flow in Q1 2025 3 | Hall of Fame music icon George Clinton to launch 'The FUNK' by Khalifa Kush Top Cannabis Stocks Apr. 25 to May. 02, 2025 1. | 5,763 views | Canopy Growth Corp. 2. | 5,521 views | Medipharm Labs Corp. 3. | 5,387 views | Tilray Brands Inc. 4. | 4,104 views | Curaleaf Holdings Inc. 5. | 730 views | Organigram Holdings Inc. 6. | 514 views | Aurora Cannabis Inc. The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.
The Market Online
28-04-2025
- Business
- The Market Online
Cannabix signs distribution deal with Alco Prevention Canada
Cannabix Technologies (CSE:BLO), an innovator in cannabis and alcohol breathalyzers, signed a non-exclusive North American distribution agreement with Alco Prevention Canada Montreal-based Alco Prevention boasts 4,000 points of sale and representation by 45 agents worldwide Cannabix develops cannabis and alcohol breathalyzer technologies for workplaces, law enforcement and other retail and professional environments Cannabix stock has added 96.88 per cent year-over-year but only 50 per cent since 2020 Cannabix Technologies (CSE:BLO), an innovator in cannabis and alcohol breathalyzers, signed a non-exclusive North American distribution agreement with Alco Prevention Canada. Montreal-based Alco Prevention specializes in consumer electronic breathalyzers, breathalyzer rentals and drug screening tests with 4,000 points of sale and representation by 45 agents worldwide. The agreement covers Cannabix's Breath Logix autonomous alcohol breathalyzer devices, whose patent pending pre-calibrated cartridge system promises to save time and money associated with calibration equipment and site visits from technicians. The technology can also take pictures to record identity and send blood alcohol content readings via text message, e-mail and dedicated web portal while logging them for future reference. Cannabix is in numerous discussions with other distributors in North America and internationally. Leadership insights 'The Breath Logix alcohol device is one of the most compact and feature-rich devices I have seen in a long time,' Stephane Maurais, general manager of Alco Prevention, said in a statement. 'The device is well-suited for employer pre-access, work sites, construction, bars, hotels, restaurants and other safety sensitive environments. The device allows employees and patrons to self-test for breath alcohol, avoiding the cost of having to pay an administrator – this saves time and money for customers and makes workplace safety programs easier to deploy. We are very pleased to represent this Canadian-built product.' 'Cannabix is delivering truly innovative new technologies in breath testing to the marketplace,' added Rav Mlait, Cannabix Technologies' chief executive officer. 'Breath testing for marijuana and alcohol is a growing segment, ripe for innovation and disruptive technologies – this has been our focus and we look forward to reaching new milestones in 2025.' About Cannabix Technologies Cannabix develops cannabis and alcohol breathalyzer technologies for workplaces, law enforcement and other retail and professional environments. Cannabix stock (CSE:BLO) is up by 10.53 per cent on the news trading at C$0.63 as of 10:58 am ET. The stock has added 96.88 per cent year-over-year but only 50 per cent since 2020. Join the discussion: Find out what everybody's saying about this cannabis technology stock's deal with Alco Prevention Canada on the Cannabix Technologies Inc. Bullboard and check out Stockhouse's stock forums and message boards. The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here. (Top image of Cannabix's Breath Logix alcohol screening devices: Cannabix Technologies)
